Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€27.00

€27.00

-1.450%
-0.4
-1.450%
-
 
20.03.26 / Tradegate WKN: A3CNHV / Name: Polypeptide Group / Stock / ? /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

Financial data and news for Polypeptide Group

sharewise wants to provide you with the best news and tools for Polypeptide Group, so we directly link to the best financial data sources.

News

PolyPeptide strengthens financing structure through expansion of existing credit facility
PolyPeptide strengthens financing structure through expansion of existing credit facility
PolyPeptide strengthens financing structure through expansion of existing credit facility
PolyPeptide publishes invitation to the annual General Meeting 2026
PolyPeptide publishes invitation to the annual General Meeting 2026
PolyPeptide publishes invitation to the annual General Meeting 2026
PolyPeptide delivers strong revenue growth and marked improvement in profitability
PolyPeptide delivers strong revenue growth and marked improvement in profitability
PolyPeptide delivers strong revenue growth and marked improvement in profitability
PolyPeptide successfully closes financial year 2025 with strong revenue growth and marked improvement in profitability
PolyPeptide successfully closes financial year 2025 with strong revenue growth and marked improvement in profitability
PolyPeptide successfully closes financial year 2025 with strong revenue growth and marked improvement in profitability
PolyPeptide and Lupin Manufacturing Solutions Form Strategic Alliance to Meet Growing Demand for Peptide Supply in Metabolic Therapies
PolyPeptide and Lupin Manufacturing Solutions Form Strategic Alliance to Meet Growing Demand for Peptide Supply in Metabolic Therapies
PolyPeptide and Lupin Manufacturing Solutions Form Strategic Alliance to Meet Growing Demand for Peptide Supply in Metabolic Therapies
PolyPeptide Group achieves significant milestone in Malmö expansion project
PolyPeptide Group achieves significant milestone in Malmö expansion project
PolyPeptide Group achieves significant milestone in Malmö expansion project